You are here
Congressional panel releases details of Trump pressure on FDA for discredited hydroxychloroquine COVID treatment
Primary tabs
Congressional panel releases details of Trump pressure on FDA for discredited hydroxychloroquine COVID treatment
Wed, 2022-08-24 17:51 — mike kraftTop Trump administration officials pressured the Food and Drug Administration (FDA) to reauthorize the discredited COVID-19 treatment hydroxychloroquine, and to speed up the release of the first COVID-19 vaccines, according to a new report Democrats on the House select coronavirus subcommittee released Wednesday.
Emails, text messages and testimony obtained by the committee show the Trump White House “exerted extreme and inappropriate pressure” on the FDA to reauthorize hydroxychloroquine even after it was shown to be ineffective and potentially dangerous.
Administration officials like trade adviser Peter Navarro enlisted outside allies like Fox News host Laura Ingraham and daytime TV talk show host Mehmet Oz — now the GOP nominee for Senate in Pennsylvania — to amplify pressure on the FDA to authorize hydroxychloroquine, a drug normally used to treat malaria and lupus, as a COVID-19 treatment.
...
Recent Comments